CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Jul 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-07-18

Reporting Person: MAHONEY DAVID L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-18	Common Stock	M	6091	$2.23	Acquired	1141764	Indirect
2017-07-18	Common Stock	S	6091	$12.5002	Disposed	1135673	Indirect
2017-07-19	Common Stock	M	16915	$2.23	Acquired	1152588	Indirect
2017-07-19	Common Stock	S	16915	$12.5012	Disposed	1135673	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-18	Stock Option (Right to Buy)	$2.23	M	6091	Disposed	2018-06-09	Common Stock (6091)	Direct
2017-07-19	Stock Option (Right to Buy)	$2.23	M	16915	Disposed	2018-06-09	Common Stock (16915)	Direct

Footnotes

F1: These transactions are made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.50 to $12.505 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3: Fully exercisable.